비알코올성 지방간염 치료를 위한 세마글루타이드

본 발명은 비알코올성 지방간염의 치료를 위한 의료 요법에서 GLP-1 수용체 작용제 세마글루티드의 용도에 관한 것이다. The present invention is directed to use of the GLP-1 receptor agonist semaglutide in medical therapy for the treatment of non-alcoholic steatohepatitis....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HANSEN MORTEN, TORSTENSON CARL RICHARD, PALLE MADS SUNDBY, DAMGAARD LARS HOLM, LINDER MARTIN
Format: Patent
Sprache:kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HANSEN MORTEN
TORSTENSON CARL RICHARD
PALLE MADS SUNDBY
DAMGAARD LARS HOLM
LINDER MARTIN
description 본 발명은 비알코올성 지방간염의 치료를 위한 의료 요법에서 GLP-1 수용체 작용제 세마글루티드의 용도에 관한 것이다. The present invention is directed to use of the GLP-1 receptor agonist semaglutide in medical therapy for the treatment of non-alcoholic steatohepatitis.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20230015884A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20230015884A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20230015884A3</originalsourceid><addsrcrecordid>eNrjZHB-vbPlzdSeN3unvJmx5k3LRoU3yxteb1j5akPLm-l7FN7snPF6cc_rpUDWnJa3U-covGnZ8Xp5x6sdDa8Xr3jb3PBm7pbXk-fwMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JJ47yAjAyNjAwNDUwsLE0dj4lQBAFY0R60</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>비알코올성 지방간염 치료를 위한 세마글루타이드</title><source>esp@cenet</source><creator>HANSEN MORTEN ; TORSTENSON CARL RICHARD ; PALLE MADS SUNDBY ; DAMGAARD LARS HOLM ; LINDER MARTIN</creator><creatorcontrib>HANSEN MORTEN ; TORSTENSON CARL RICHARD ; PALLE MADS SUNDBY ; DAMGAARD LARS HOLM ; LINDER MARTIN</creatorcontrib><description>본 발명은 비알코올성 지방간염의 치료를 위한 의료 요법에서 GLP-1 수용체 작용제 세마글루티드의 용도에 관한 것이다. The present invention is directed to use of the GLP-1 receptor agonist semaglutide in medical therapy for the treatment of non-alcoholic steatohepatitis.</description><language>kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230131&amp;DB=EPODOC&amp;CC=KR&amp;NR=20230015884A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230131&amp;DB=EPODOC&amp;CC=KR&amp;NR=20230015884A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HANSEN MORTEN</creatorcontrib><creatorcontrib>TORSTENSON CARL RICHARD</creatorcontrib><creatorcontrib>PALLE MADS SUNDBY</creatorcontrib><creatorcontrib>DAMGAARD LARS HOLM</creatorcontrib><creatorcontrib>LINDER MARTIN</creatorcontrib><title>비알코올성 지방간염 치료를 위한 세마글루타이드</title><description>본 발명은 비알코올성 지방간염의 치료를 위한 의료 요법에서 GLP-1 수용체 작용제 세마글루티드의 용도에 관한 것이다. The present invention is directed to use of the GLP-1 receptor agonist semaglutide in medical therapy for the treatment of non-alcoholic steatohepatitis.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB-vbPlzdSeN3unvJmx5k3LRoU3yxteb1j5akPLm-l7FN7snPF6cc_rpUDWnJa3U-covGnZ8Xp5x6sdDa8Xr3jb3PBm7pbXk-fwMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JJ47yAjAyNjAwNDUwsLE0dj4lQBAFY0R60</recordid><startdate>20230131</startdate><enddate>20230131</enddate><creator>HANSEN MORTEN</creator><creator>TORSTENSON CARL RICHARD</creator><creator>PALLE MADS SUNDBY</creator><creator>DAMGAARD LARS HOLM</creator><creator>LINDER MARTIN</creator><scope>EVB</scope></search><sort><creationdate>20230131</creationdate><title>비알코올성 지방간염 치료를 위한 세마글루타이드</title><author>HANSEN MORTEN ; TORSTENSON CARL RICHARD ; PALLE MADS SUNDBY ; DAMGAARD LARS HOLM ; LINDER MARTIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20230015884A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HANSEN MORTEN</creatorcontrib><creatorcontrib>TORSTENSON CARL RICHARD</creatorcontrib><creatorcontrib>PALLE MADS SUNDBY</creatorcontrib><creatorcontrib>DAMGAARD LARS HOLM</creatorcontrib><creatorcontrib>LINDER MARTIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HANSEN MORTEN</au><au>TORSTENSON CARL RICHARD</au><au>PALLE MADS SUNDBY</au><au>DAMGAARD LARS HOLM</au><au>LINDER MARTIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>비알코올성 지방간염 치료를 위한 세마글루타이드</title><date>2023-01-31</date><risdate>2023</risdate><abstract>본 발명은 비알코올성 지방간염의 치료를 위한 의료 요법에서 GLP-1 수용체 작용제 세마글루티드의 용도에 관한 것이다. The present invention is directed to use of the GLP-1 receptor agonist semaglutide in medical therapy for the treatment of non-alcoholic steatohepatitis.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language kor
recordid cdi_epo_espacenet_KR20230015884A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 비알코올성 지방간염 치료를 위한 세마글루타이드
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T03%3A45%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HANSEN%20MORTEN&rft.date=2023-01-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20230015884A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true